Progesterone Capsule
Product Images NDC 69452-234

6 FDA label images from Bionpharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Progesterone (NDC 69452-234). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Structure01)

Chemical Structure (Structure01)
Chemical structure of progesterone, showing its steroid backbone with ketone groups and methyl substitutions, consistent with the active ingredient progesterone.*
FDA Label Image

Graph1 (Figure01)

Graph1 (Figure01)
A line graph showing the probability of hyperplasia over time in months for patients on medication. The x-axis represents time on medication from 0 to 36 months, and the y-axis represents the probability of hyperplasia from 0 to 1. Three treatment groups are compared: Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only. The total number of patients remaining at each time interval is indicated below the x-axis.*
FDA Label Image

100 mg Capsules (Image01)

100 mg Capsules (Image01)
Label for Progesterone Capsules 100 mg, oral dosage form, by Bionpharma Inc. The label specifies 100 count capsules, with warnings about peanut allergy and storage instructions at 20°-25°C. It includes a barcode, QR code for patient information, and notes the product is Rx only.*
FDA Label Image

Image02 (Image02)

Image02 (Image02)
Label for Progesterone Capsules 100 mg oral capsules by Bionpharma Inc., packaged as 100 count. The label includes warnings not to use if allergic to peanuts and directs pharmacists to dispense with a patient information leaflet. Storage instructions and manufacturer details (made in India) are provided along with an NDC barcode and QR code for patient information access.*
FDA Label Image

200 mg Capsules (Image03)

200 mg Capsules (Image03)
Label for Progesterone Capsules 200 mg by Bionpharma Inc. The label specifies 100 count capsules, oral route, and includes a barcode, dosage information indicating each capsule contains 200 mg micronized progesterone, storage instructions, and a QR code for patient information. It also warns against use if allergic to peanuts and states Rx only.*
FDA Label Image

Image04 (Image04)

Image04 (Image04)
Packaging label for Progesterone Capsules 200 mg oral capsules by Bionpharma Inc. The label indicates a 100 count package with instructions to dispense with a patient information leaflet. It warns against use if allergic to peanuts and includes storage conditions, manufacturing details, and a QR code for additional patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.